BRIEF-Transition Therapeutics reports Q3 loss per share $0.11
May 11 (Reuters) - Transition Therapeutics Inc
* Q3 loss per share $0.11
* Existing cash resources should enable co to execute business plan and meet projected cash requirements beyond next 12 months Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2016 All rights reserved.